Skip to main content
News, talk and articles

The latest news from PTC

  1. In it Together: Rare Disease Day 2024

    Rare Disease Day, which takes place every year on the last day of February, is a global movement aimed at raising awareness of the 7,000+ rare diseases and more than 300 million people worldwide who live with a rare disease. With our deep experience in the rare disease space for more than 25 years and…
    Rare Disease Community
    February 21, 2024
    3 minutes
    Read More
  2. Take on Duchenne Podcast: Nutrition and Duchenne

    In this podcast episode we are discussing the topic of Nutrition and Duchenne with our guest speaker, Dr. Kindann Fawcett, Behavioral Health Scientist, Dietitian and Caregiver to her son with Duchenne Muscular Dystrophy.  Our conversation with Dr. Kindann Fawcett explores; Tune in to learn more about this topic. Visit the Take on Duchenne: North America…
    Rare Disease Community
    December 19, 2023
    2 minutes
    Read More
  3. A Whole Team in One Molecule: PTC’s Splicing Platform

    There are many things that make PTC Therapeutics truly unique, and the splicing platform is one of them. Here, “splicing” refers to PTC’s scientific platform that takes aim at modulating pre-messenger RNA (pre-mRNA) splicing to control protein production. This scientific platform together with the technology that powers it, enables the identification of small molecules, which…
    Science & Innovation
    December 18, 2023
    2 minutes
    Read More
  4. PTC’s New Horizons in Kazakhstan

    PTC’s geographical footprint continues to expand as we fulfill our mission to provide access to best-in-class treatments for more patients around the world. Our recent expansion into Kazakhstan is a further achievement in this mission. In the first quarter of 2023, PTC officially opened its affiliate office in Almaty and hired the first employees.  Today,…
    Business & Finance, Our Culture
    December 13, 2023
    2 minutes
    Read More
  5. Luke & Elliott: Two Paths to Duchenne

    The bond between Luke and Elliott, who lives with Duchenne, is the foundation for new life paths.
    Rare Disease Community, Rare Journeys
    December 5, 2023
    3 minutes
    Read More
  6. An Important Job and Rewarding Career

    It’s Calum Sinclair’s job to help ensure patient safety. As the Vice President, Global Pharmacovigilance (PV) at PTC, Calum leads a global team who collect, assess, and monitor the use and safety of PTC’s medicines, from clinical to commercial setting.   It’s a highly important role that Calum candidly enjoys and has throughout his extensive career…
    Science & Innovation
    December 5, 2023
    2 minutes
    Read More
  7. Owning Your Rare Disease Story

    Kevin, who lives with PKU, shares his passion for storytelling.
    Rare Disease Community, Rare Journeys
    December 3, 2023
    4 minutes
    Read More
  8. PTC Cares™: Supporting Specialty Pharmacy

    Navigating a rare disease diagnosis and treatment can be time consuming and overwhelming, from getting a prescription, working through insurance coverage and getting the medication on time. For people living with rare diseases taking a PTC treatment, PTC Cares is here to help. PTC Cares helps take care of treatment coordination, so patients with a rare disease…
    Rare Disease Community
    November 28, 2023
    2 minutes
    Read More
  9. Jessica’s Many Crowns and Titles – Including Duchenne Advocate

    Jessica uses her platform and titles, including Mrs. NY International, to advocate for Duchenne.
    Rare Disease Community, Rare Journeys
    November 21, 2023
    3 minutes
    Read More
  10. PTC Cares™: Providing Financial Assistance

    Navigating a rare disease diagnosis and treatment can be overwhelming, from getting a prescription, working through insurance coverage and getting the medication on time. For people living with rare diseases taking a PTC treatment, PTC Cares is here to help. PTC Cares helps take care of treatment coordination, so patients with a rare disease and their families…
    Rare Disease Community
    November 21, 2023
    2 minutes
    Read More